Latest filing published 02 Nov 2023 for Eiger BioPharmaceuticals, Inc., €2,964.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Richard A. Kayne has filed trades across 7 companies (mainly through SEC (Form 4)), most often in Kayne Anderson Energy Infrastructure Fund, Inc., Freshpet, Inc. and Kayne Anderson Energy Development Co. Between 15 February 2006 and 2 November 2023, the trades on record add up to 89 filings.
In open-market terms, that means 32 purchases worth €8.3M on one side and 16 sales worth €723.9M on the other. The totals do not cover 1 filing with an undisclosed amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2023 to date brings 5 purchases and no sales.
A typical purchase (the median) is worth €136k. 8 out of 9 purchases came within 30 days of a purchase by at least one other insider of the same company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.
The record was last updated on 2 November 2023 with an open-market purchase (€3,041) in Eiger BioPharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations